AUPH
Aurinia Pharmaceuticals Inc
$8.6
Earnings Summary
Revenue | $54.52Mn |
Net Profits | $-13.45Mn |
Net Profit Margins | -24.67% |
Highlights
Aurinia Pharmaceuticals Inc’s revenue fell -2.27% since last year same period to $54.52Mn in the Q3 2023. On a quarterly growth basis, Aurinia Pharmaceuticals Inc has generated 31.38% jump in its revenue since last 3-months.
Aurinia Pharmaceuticals Inc’s net profit fell -49.59% since last year same period to $-13.45Mn in the Q3 2023. On a quarterly growth basis, Aurinia Pharmaceuticals Inc has generated -17.01% fall in its net profits since last 3-months.
Aurinia Pharmaceuticals Inc’s net profit margin fell -53.06% since last year same period to -24.67% in the Q3 2023. On a quarterly growth basis, Aurinia Pharmaceuticals Inc has generated 10.94% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Aurinia Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.16 |
EPS Estimate Current Year | -0.16 |
Highlights
Aurinia Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.16 - a 5.88% jump from last quarter’s estimates.
Aurinia Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.16.
Key Ratios
Key ratios of the Aurinia Pharmaceuticals Inc post its Q3 2023 earnings
Earning Per Share (EPS) | -0.09 |
Highlights
Aurinia Pharmaceuticals Inc’s earning per share (EPS) fell -50% since last year same period to -0.09 in the Q3 2023. This indicates that the Aurinia Pharmaceuticals Inc has generated -50% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-02 | -0.17 | -0.09 | 47.06% |
2023-05-04 | -0.22 | -0.18 | 18.18% |
2023-08-03 | -0.18 | -0.08 | 55.56% |
₹0 US Stocks a/c Opening Fee